Hubei Biocause Pharmaceutical Co., Ltd. (SHE:000627)
China · Delayed Price · Currency is CNY 1.470
-0.060 (-3.92%)
Aug 1, 2025, 2:45 PM CST
Hubei Biocause Pharmaceutical Company Description
Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China.
It also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, the company is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride.
It exports its products to approximately 85 countries, including the United States, the European Union, and internationally.
The company is based in Jingmen, China.
Hubei Biocause Pharmaceutical Co., Ltd.
| Country | China |
| Industry | Insurance - Life |
| Sector | Financials |
| Employees | 1,765 |
| CEO | Wenxia Zhou |
Contact Details
Address: 122-132 Yangwan Road Jingmen, 448000 China | |
| Phone | 86 27 6565 1730 |
| Website | biocause.com |
Stock Details
| Ticker Symbol | 000627 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000000F48 |
| SIC Code | 2800 |
Key Executives
| Name | Position |
|---|---|
| Wenxia Zhou | Vice Chairman and GM |
| Dali Chen | Chief Financial Officer and Director |
| Fei Long | Secretary of the Board and Non-Independent Director |